Representation of the elderly, women, and minorities in heart failure clinical trials.

No abstract is available for this paper.

• Publication year

  2002

• Venue

  Archives of Internal Medicine

• Publication date

  2002-08-12

• Fields of study

  Medicine, Sociology

• Identifiers
  DOI 10.1001/ARCHINTE.162.15.1682PMID 12153370
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Coronary artery bypass surgery.

  2003cited by this paper
• Age- and gender-specific differences in left and right ventricular cardiac function and mass determined by cine magnetic resonance imaging

  2000cited by this paper
• Epidemiology, aetiology, and prognosis of heart failure

  2000cited by this paper
• The influence of gender on the outcome of coronary artery bypass surgery.

  2000cited by this paper
• A national survey of heart failure in French hospitals. The Myocardiopathy and Heart Failure Working Group of the French Society of Cardiology, the National College of General Hospital Cardiologists and the French Geriatrics Society.

  2000cited by this paper
• Long-term outcome of myocardial infarction in women and men: a population perspective.

  2000cited by this paper
• National hospital discharge survey: annual summary, 1998.

  2000cited by this paper
• The effect of race on coronary bypass operative mortality.

  2000cited by this paper
• Enrollment of women in cardiovascular clinical trials funded by the National Heart, Lung, and Blood Institute.

  2000cited by this paper
• Underrepresentation of patients 65 years of age or older in cancer-treatment trials.

  1999cited by this paper
• Comparison of incidences of congestive heart failure in older African-Americans, Hispanics, and whites.

  1999cited by this paper
• Congestive heart failure in subjects with normal versus reduced left ventricular ejection fraction: prevalence and mortality in a population-based cohort.

  1999cited by this paper
• Are the Elderly Underrepresented in Clinical Drug Trials?

  1999cited by this paper
• Prevalence of heart failure and left ventricular dysfunction in the general population; The Rotterdam Study.

  1999cited by this paper
• Gender differences in survival in advanced heart failure. Insights from the FIRST study.

  1999cited by this paper
• Incidence and aetiology of heart failure; a population-based study.

  1999cited by this paper
• Threats to Applicability of Randomised Trials: Exclusions and Selective Participation

  1999cited by this paper
• Congestive heart failure with preserved systolic function: is it a woman's disease?

  1999cited by this paper
• Representation of blacks, women, and the very elderly (aged > or = 80) in 28 major randomized clinical trials.

  1999cited by this paper
• Attitudes and beliefs of african americans toward participation in medical research

  1999cited by this paper
• Association of body mass, gender and race with heart failure primarily due to hypertension.

  1999cited by this paper
• Gender specific differences in left ventricular adaptation to obesity and hypertension

  1998cited by this paper
• Normal left ventricular ejection fraction in older persons with congestive heart failure.

  1998cited by this paper
• Gender differences in 1-year survival and quality of life among patients admitted with congestive heart failure.

  1998cited by this paper
• Congestive heart failure in the community: a study of all incident cases in Olmsted County, Minnesota, in 1991.

  1998cited by this paper
• Cardiovascular Disease in Women: Gender-Specific Aspects of Hypertension and the Consequences of Treatment

  1998cited by this paper
• Usefulness of peak oxygen consumption in predicting outcome of heart failure in women versus men.

  1997cited by this paper
• Long-term follow-up of gender-specific outcomes after thrombolytic therapy for acute myocardial infarction from the GUSTO-I trial. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries.

  1997cited by this paper
• Congestive heart failure in old age: prevalence, mechanisms and 4‐year prognosis in the Helsinki Ageing Study

  1997cited by this paper
• Gender-specific associations of the fibrinogen B beta 448 polymorphism, fibrinogen levels, and acute cerebrovascular disease.

  1997cited by this paper
• Predictors of survival and the role of gender in postoperative myocardial infarction.

  1997cited by this paper
• Long-Term Follow-Up of Gender-Specific Outcomes After Thrombolytic Therapy for Acute Myocardial Infarction from the GUSTO-I Trial

  1997cited by this paper
• Congestive heart failure in patients with coronary artery disease: the gender paradox.

  1997cited by this paper
• CONGESTIVE HEART FAILURE IN OLDER ADULTS * : Epidemiology, Pathophysiology, and Etiology of Congestive Heart Failure in Older Adults

  1997cited by this paper
• Clinical Trial Participant Satisfaction: Survey of SHEP Enrollees

  1997cited by this paper
• Why are African Americans under-represented in medical research studies? Impediments to participation.

  1997cited by this paper
• Influence of gender on short- and long-term mortality after acute myocardial infarction. TRACE study group.

  1996cited by this paper
• Characteristics and mortality outcomes of thrombolysis trial participants and nonparticipants: a population-based comparison.

  1996cited by this paper
• Age and gender differences in left ventricular function among patients with stable angina and a matched control group. A report from the Angina Prognosis Study in Stockholm.

  1996cited by this paper
• Female sex is associated with increased mortality and morbidity early, but not late, after coronary artery bypass grafting.

  1996cited by this paper
• Gender-specific criteria and performance of the exercise electrocardiogram.

  1995cited by this paper
• Gender-specific cardiovascular adaptation due to circadian blood pressure variations in essential hypertension.

  1995cited by this paper
• Heart Failure with Normal Systolic Function: A Common Disorder in Older People

  1995cited by this paper
• Characteristics and prognosis of non-participants of a multi-centre trial of long-term anticoagulant treatment after myocardial infarction.

  1995cited by this paper
• Inclusion of women and minorities in clinical trials and the NIH Revitalization Act of 1993--the perspective of NIH clinical trialists.

  1995cited by this paper
• Representation of older patients in cancer treatment trials.

  1994cited by this paper
• Risk stratification for long-term outcome after elective coronary angioplasty: a multivariate analysis of 5,000 patients.

  1994cited by this paper
• Representation of older patients in cancer treatment trials

  1994cited by this paper
• Long-term survival after pacemaker implantation for heart block in patients > or = 65 years.

  1994cited by this paper
• The epidemiology of heart failure: the Framingham Study.

  1993cited by this paper
• The exclusion of the elderly and women from clinical trials in acute myocardial infarction.

  1992cited by this paper
• Do treatment protocols improve end results? A study of survival of patients with multiple myeloma in Finland.

  1989cited by this paper
• Representation of American blacks in clinical trials of new drugs.

  1989cited by this paper
• Participants in prospective, randomized clinical trials for resected non‐small cell lung cancer have improved survival compared with nonparticipants in such trials

  1985cited by this paper

• Survival benefit of guideline-directed medical therapy in older patients with heart failure: a systematic review and meta-analysis

  2026cites this paper
• Uncovering the Hidden Hurdles: Exploring Challenges in Pediatric Pharmacovigilance in the Netherlands

  2025cites this paper
• A Framework for Generating Realistic Synthetic Tabular Data in a Randomized Controlled Trial Setting

  2025cites this paper
• Effects of Endurance and Resistance Training on Cardiovascular Outcomes and Quality of Life in Patients with Heart Failure with Reduced Ejection Fraction: A Structured Narrative Review

  2025cites this paper
• Age- and Sex-related Differences in Heart Failure Characteristics and Treatment Patterns Across the Ejection Fraction Spectrum: First Data from the BRING-UP-3 Heart Failure Study.

  2025cites this paper
• Get With The Guidelines-Heart Failure: Twenty Years in Review, Lessons Learned, and the Road Ahead

  2025cites this paper
• Smartphone barrier: uncovering the digital divide in mHealth prevention among disadvantaged middle-aged and older-aged UK communities

  2025cites this paper
• Inclusion and reporting by age, sex, and ethnicity in clinical studies of high-risk medical devices approved in the European Union

  2025cites this paper
• Heart Failure in Older Patients: An Update

  2025cites this paper
• Is it time to revisit the scoring of slow wave (N3) sleep?

  2025cites this paper
• Association of Cardiovascular-Kidney-Metabolic Overlap with Physical Function and Prognosis in Older Patients with Heart Failure: A Post-hoc Analysis of the FRAGILE-HF and SONIC-HF.

  2025cites this paper
• The silent exclusion: rethinking eligibility and generalizability in clinical trials

  2025cites this paper
• Cardiovascular Health in Women-Across the Lifespan.

  2025cites this paper
• Strategies to enhance recruitment of female participants to cardiovascular research: a joint British Cardiovascular Societies’ consensus document in collaboration with the British Heart Foundation Clinical Research Collaborative

  2025cites this paper
• Enrollment of all-female and lactating or pregnant female participants in cardiovascular trials

  2025cites this paper
• Ethics of extra-protocol pre-screening in clinical trials

  2025cites this paper
• Maximum tolerated medication dose and other predictors of mortality in heart failure with reduced ejection fraction: retrospective cohort study

  2025cites this paper
• Patient-Reported Outcomes as End Points in Heart Failure Trials.

  2025cites this paper
• Excessive Initial Renal Function Decline Following Sodium-Glucose Cotransporter-2 Inhibitor Treatment Predicts Major Adverse Cardiorenal Outcomes.

  2025cites this paper
• Mineralocorticoid receptor antagonist (MRA) use in UK heart failure care: a national primary care cohort study

  2025cites this paper
• The impact of behavioral nudges on clinical trial retention of men with a history of violent offending

  2025cites this paper
• Cardiovascular magnetic resonance imaging markers of ageing: a multi-centre, cross-sectional cohort study

  2025cites this paper
• Transforming Cancer Care: A Narrative Review on Leveraging Artificial Intelligence to Advance Immunotherapy in Underserved Communities

  2025cites this paper
• Pre‐Screening in Clinical Trials: Incentives, Behaviours, Consequences

  2025cites this paper
• Bridging inequity gaps in healthcare through tailored support: implementation perspectives of the Social Health Bridge-Building Programme

  2025cites this paper
• Cardiac PAD2 Expression and Myocardial Citrullination Decline with Age in Female Mice Independent of Estrogen.

  2025cites this paper
• Eurasian Association of Cardiology (EAC)/ National Society of Heart Failure And Myocardial Disease (NSHFMD) guidelines for the diagnosis and treatment of chronic heart failure (2024)

  2024cites this paper
• Trends in patient representation in low back pain pharmacological randomized clinical trials, 2011-2020: A systematic review.

  2024cites this paper
• Peer Engagement: On Reflecting Student Diversity in a Research Trial

  2024cites this paper
• 2024 Clinical practice guidelines for Chronic heart failure

  2024cites this paper
• Participation and engagement in online cognitive testing

  2024cites this paper
• Social determinants of distress in South Asian men with long-term conditions: a qualitative study in primary care

  2024cites this paper
• Assessing the Relationship between Radiology Department Research Funding and Institutional Community Inclusion and Investment.

  2024cites this paper
• Reducing research participant disparities through use of a co-developed video intervention: A cohort nested pre-post study

  2024cites this paper
• Impact and consequences of the error of estimated GFR in patients with heart failure

  2024cites this paper
• Enrollment of Females in Randomized Trials for Glucagon-Like Peptide 1 Receptor Agonists

  2024cites this paper
• Underrepresentation of women in cardiovascular disease clinical Trials—What’s in a Name?

  2024cites this paper
• Clinical Trial Exclusion Criteria Affect Trial Inclusivity by Race and Sex

  2024cites this paper
• Association between socioeconomic position and discontinuation of pharmacotherapy for heart failure after cardiac resynchronization therapy.

  2024cites this paper
• Investigation of left ventricular ejection fraction in a Swiss heart failure population: Insights into mortality and sex differences

  2024cites this paper
• Shining a spotlight on the inclusion of disabled participants in clinical trials: a mixed methods study

  2024cites this paper
• Transparent and Robust Artificial Intelligence-Driven Electrocardiogram Model for Left Ventricular Systolic Dysfunction

  2024cites this paper
• Cardiovascular and mortality benefits of sodium-glucose cotransporter-2 inhibitors and glucagon-like peptide 1 receptor agonists as third-step glucose-lowering medicine in patients with type 2 diabetes: a retrospective cohort analysis

  2024cites this paper
• The Influence of Estrogen on Myocardial Post-Translational Modifications and Cardiac Function in Women.

  2024cites this paper
• Analysis of eligibility criteria clusters based on large language models for clinical trial design

  2024cites this paper
• Adjustment of selection bias for clinical trials: a simulation study

  2024cites this paper
• Evaluation of Adherence to European Society of Cardiology Guidelines for Heart Failure Patients in Shahid Modarres Hospital

  2024cites this paper
• CLINICAL AND PROGNOSTIC FEATURES OF ELDERLY PATIENTS WITH UNSTABLE ANGINA PECTORIS UNDERGOING CONSERVATIVE TREATMENT DEPENDING ON LEFT VENTRICULAR EJECTION FRACTION

  2023cites this paper
• Accounting for complexity in critical realist trials: the promise of PLS-SEM

  2023cites this paper
• Characteristics, management, and mid-term prognosis of older adults with cardiogenic shock admitted to intensive care units: Insights from the FRENSHOCK registry.

  2023cites this paper
• Recruitment and Enrollment of Low-income, Minority Residents of Urban Public Housing into Research

  2023cites this paper
• Risk stratification for ventricular tachyarrhythmia in patients with nonischemic cardiomyopathy

  2023cites this paper
• The value of multiparametric prediction scores in heart failure varies with the type of follow‐up after discharge: a comparative analysis

  2023cites this paper
• The Representation of Females in Studies on Antihypertensive Medication over the Years: A Scoping Review

  2023cites this paper
• Identifying modifiable factors and their joint effect on dementia risk in the UK Biobank

  2023cites this paper
• Temporal changes in characteristics and external validity of randomized controlled trials in older people from 2012 to 2019

  2023cites this paper
• Age-related outcomes in patients with cardiogenic shock stratified by etiology.

  2023cites this paper
• Adjuvant gemcitabine after resection of pancreatic cancer without significant difference in overall survival: a retrospective cohort study

  2023cites this paper
• Long-term outcome of cardiac resynchronization therapy patients in the elderly

  2023cites this paper
• Nomogram to predict the incidence of new-onset heart failure after acute coronary syndrome among women

  2023cites this paper
• Trends and outcomes of cardiogenic shock in Asian populations compared with non-Asian populations in the US: NIS Analysis (2002-2019)

  2023cites this paper
• Using Patient Perspectives to Inform Better Clinical Trial Design and Conduct: Current Trends and Future Directions

  2023cites this paper
• Investigating Potential Gender-Based Differential Item Functioning for Items in the Kansas City Cardiomyopathy Questionnaire (KCCQ) Physical Limitations Domain

  2023cites this paper
• A Randomized Prospective Survey Targeting Knowledge, Barriers, Facilitators and Readiness to Participation in Dementia Research

  2023cites this paper
• Serum Human Epididymis Protein 4 as a Prognostic Predictor of New-Onset Heart Failure among Women after Acute Coronary Syndrome: A Single-Center Retrospective Study

  2023cites this paper
• von Willebrand factor, ADAMTS-13, and thrombospondin 1 in relation to clinical outcomes in elderly patients with a recent myocardial infarction

  2023cites this paper
• Already low drug dose antagonism of the renin-angiotensin aldosterone system decreases 1-year mortality and rehospitalization in old heart failure patients.

  2022cites this paper
• Benefits of heart failure-specific pharmacotherapy in frail hospitalised patients: a cross-sectional study

  2022cites this paper
• Human Papillomavirus-Associated Oropharyngeal Squamous Cell Carcinoma: A Systematic Review and Meta-Analysis of Clinical Trial Demographics

  2022cites this paper
• A community-partnered approach for diversity in COVID-19 vaccine clinical trials

  2022cites this paper
• Sex and Race Reporting and Representation in Noncancerous Voice Clinical Trials: A Meta-Analysis of National Institutes of Health-Registered Research Between 1988 and 2021.

  2022cites this paper
• Patient-centred clinical trial design

  2022cites this paper
• Women: Diet, Cardiometabolic Health, and Functional Medicine.

  2022cites this paper
• Sex and Gender-Related Issues in Heart Failure.

  2022cites this paper
• Motives for and Barriers to Research Participation Among Racially and Ethnically Diverse Veterans.

  2022cites this paper
• A novel approach to reducing disparities in health outcomes by enhancing interpretation of cancer clinical trials for underrepresented patient groups.

  2022cites this paper
• Multi-disciplinary fairness considerations in machine learning for clinical trials

  2022cites this paper
• Do PRO measures function the same way for all individuals with heart failure?

  2022cites this paper
• Women's representation in venous thromboembolism randomized trials and registries: The illustrative example of direct oral anticoagulants for acute treatment.

  2022cites this paper
• Sex Differences in Therapies for Heart Failure.

  2022cites this paper
• Representation of women in heart failure clinical trials: Barriers to enrollment and strategies to close the gap

  2022cites this paper
• 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure

  2022cites this paper
• Improving Enrollment of Underrepresented Racial and Ethnic Populations in Heart Failure Trials: A Call to Action From the Heart Failure Collaboratory.

  2022cites this paper
• Can telepsychiatry bridge the treatment gap?

  2022cites this paper
• Investigating gender-based differential item functioning on the Kansas City Cardiomyopathy Questionnaire (KCCQ) using qualitative content analysis

  2022cites this paper
• Guía ESC 2021 sobre el diagnóstico y tratamiento de la insuficiencia cardiaca aguda y crónica

  2022cites this paper
• Caractéristiques et mortalité des patients avec et sans syndrome cardio-rénal traités par dialyse péritonéale en France

  2022cites this paper
• An Audit of Clinical Studies Involving Elderly Population Registered in Clinical Trials Registry of India

  2021cites this paper
• Evaluation of Drug Trials in High-, Middle-, and Low-Income Countries and Local Commercial Availability of Newly Approved Drugs

  2021cites this paper
• Barriers to and Facilitators of Recruitment of Adult African American Men for Colorectal Cancer Research: An Instrumental Exploratory Case Study

  2021cites this paper
• Use of angiotensin receptor blocker is associated with improved 1 year mortality in heart failure with mid‐range ejection fraction

  2021cites this paper
• Racial and Ethnic Diversity in Studies Funded Under the Best Pharmaceuticals for Children Act

  2021cites this paper
• Hospitalization and Mortality in Patients With Heart Failure Treated With Sacubitril/Valsartan vs. Enalapril: A Real-World, Population-Based Study

  2021cites this paper
• Using external data to assess the external validity of a randomised controlled trial

  2021cites this paper
• Beta-blocker therapy in elderly patients with renal dysfunction and heart failure

  2021cites this paper
• Identifying knowledge gaps in heart failure research among women using unsupervised machine-learning methods.

  2021cites this paper
• Building a Population Representative Pediatric Biobank: Lessons Learned From the Greater Cincinnati Childhood Cohort

  2021cites this paper
• Sociodemographic diversity in cancer clinical trials: New findings on the effect of race and ethnicity

  2021cites this paper
• Ethnicity and socioeconomic status: missing in research means missing in clinical guidance

  2021influential citation
• Sex influences the effect of adiposity on arterial stiffness and renin‐angiotensin aldosterone system activity in young adults

  2021cites this paper